24 Jun 2021 FDA Accepts Application for Genentech’s Port Delivery System With Ranibizumab (PDS) for Treatment of Wet Age-Related Macular Degeneration (AMD) Press Releases SOUTH SAN FRANCISCO, Calif.–(
24 Jun 2021 Mercy Ships International Board Announces the Appointment of Gert van de Weerdhof as Interim CEO as Current CEO Tom Stogner retires Press Releases GARDEN VALLEY, Texas–(
24 Jun 2021 Ray Pawlicki, Previously CIO at Biogen and Novartis, Joins PrecisionLife as Executive Chair to Accelerate Strategic Expansion Press Releases OXFORD, England–(
24 Jun 2021 NanoTemper Enters Protein Production Market With Andromeda, Helping Biopharma and CROs to Increase Efficiency of Expression Screening for Membrane Proteins Press Releases SOUTH SAN FRANCISCO, Calif.–(
24 Jun 2021 LYNPARZA® (olaparib) Approved in China for the Treatment of Certain Patients with BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer Press Releases KENILWORTH, N.J.–(
24 Jun 2021 Verastem Oncology Appoints Paul Bunn, M.D., and Lesley Solomon to Board of Directors Press Releases BOSTON–(
24 Jun 2021 Cybin Announces Former FDA Psychiatry Division Director Dr. Thomas Laughren has Joined Clinical Advisory Board Press Releases TORONTO–(
24 Jun 2021 Catamaran Bio and Bio-Techne Announce Expanded Collaboration for CAR‑NK Cell Manufacturing Technologies Press Releases CAMBRIDGE, Mass. & MINNEAPOLIS–(
24 Jun 2021 Alnylam Announces U.S. Food and Drug Administration Acceptance of New Drug Application for Investigational Vutrisiran for the Treatment of the Polyneuropathy of Hereditary ATTR Amyloidosis Press Releases CAMBRIDGE, Mass.–(
23 Jun 2021 Enanta Pharmaceuticals Reports Positive Data from Phase 1b Study of EDP-514, a Hepatitis B Virus (HBV) Core Inhibitor, in Viremic Chronic HBV Patients Press Releases WATERTOWN, Mass.–(
